Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Long-term impact of pretransplant and posttransplant diabetes mellitus on kidney transplant outcomes
 
  • Details
Options

Long-term impact of pretransplant and posttransplant diabetes mellitus on kidney transplant outcomes

Journal
World Journal of Surgery
Date Issued
2011-12-01
Author(s)
SHENG-WEN WU  
TUNG-WEI HUNG  
HORNG-RONG CHANG  
DOI
10.1007/s00268-011-1287-0
URI
https://www.scopus.com/pages/publications/83655167255
https://scholars.csmu.edu.tw/handle/123456789/34030
Abstract
Background: The aim of this study was to compare the impact of preexisting diabetes mellitus (pre-DM), posttransplant DM (PTDM), and non-DM on the long-term outcomes of renal transplant recipients (RTRs). Methods: This is a retrospective observational cohort study of 427 RTRs who underwent transplantation from 1999 to 2008. Patients were divided into non-DM, pre-DM, and PTDM groups. The primary outcome was the composite of doubling of the serum creatinine (SCr) level, graft failure, or death. Secondary outcomes were biopsy-proven acute rejection (BPAR), biopsy-proven interstitial fibrosis and/or tubular atrophy (IF/TA), and individual components of the primary outcome. Results: A total of 70 patients (16.4%) had pre-DM, 104 (24.2%) had PTDM, and 253 (59.3%) had non-DM. Kaplan-Meier analysis indicated significant differences in the development of the primary outcome: p = 0.003 (log rank test). Relative to the non-DM group, the pre-DM group had a 6.36-fold increased risk [95% confidence interval (CI) 2.43-16.33; p < 0.001), and the PTDM group had a 2.00-fold increased risk (95% CI 1.08-3.73; p = 0.029) for development of the primary outcome. Patients in the pre-DM group had 6.73-fold (95% CI 2.46-18.42; p < 0.001), 4.56-fold (95% CI 1.77-11.78; p = 0.002), and 13.95-fold (95% CI 2.96-65.75; p < 0.001) increased risks for the development of SCr doubling, biopsy-proven IF/TA, and death-censored graft failure, respectively. Patients in the PTDM group had a 2.09-fold (95% CI 1.10-3.99; p = 0.025), increased risk for the development of SCr doubling. Conclusions: The presence of pre-DM or PTDM significantly impaired kidney allograft outcome.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback